Literature DB >> 25602516

Contrast-induced acute kidney injury: potential new strategies.

Carlo Briguori1, Elvira Donnarumma, Cristina Quintavalle, Danilo Fiore, Gerolama Condorelli.   

Abstract

PURPOSE OF REVIEW: Contrast-induced acute kidney injury (CI-AKI) is an impairment of renal function following contrast media administration in the absence of an alternative cause. It represents a powerful predictor of poor early and late outcomes. Here, we review the major strategies to prevent CI-AKI. RECENT
FINDINGS: Hydration represents the gold standard as a prophylactic measure to prevent CI-AKI, acting by increasing urine flow rate and, thereby, by limiting the time of contact between the contrast media and the tubular epithelial cells. An optimal hydration regimen should be defined according to predefined clinical markers, such as urine flow rate, or left ventricular end-diastolic pressure. Recently, high-dose statins pretreatment has been included in the guidelines of CI-AKI prevention. However, uncertainty still exists on the efficacy of several compounds tested in both observational trials and randomized studies to prevent CI-AKI. Compounds evaluated include diuretics (furosemide), antioxidants (i.e. N-acetylcysteine and statins) and vasodilators (i.e. calcium antagonists, dopamine and fenoldopam).
SUMMARY: Hydration still represents the most reliable strategy to prevent CI-AKI. New prophylactic strategies for acute kidney injury are still under investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25602516     DOI: 10.1097/MNH.0000000000000106

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  7 in total

Review 1.  Hypoxia-Inducible Factor and Oxygen Biology in the Kidney.

Authors:  Mai Sugahara; Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Kidney360       Date:  2020-07-22

2.  Contrast induced acute kidney injury and the role of beta-blockers in its prevention.

Authors:  Umberto Barbero; Mario Iannaccone; Michele De Benedictis; Baldassarre Doronzo
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

3.  Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Heart Failure and Chronic Kidney Disease.

Authors:  Kennosuke Yamashita; Wataru Igawa; Morio Ono; Takehiko Kido; Toshitaka Okabe; Myong Hwa Yamamoto; Kisaki Amemiya; Naoei Isomura; Hiroshi Araki; Masahiko Ochiai
Journal:  Kidney Dis (Basel)       Date:  2018-11-29

4.  Preclinical Studies of a Kidney Safe Iodinated Contrast Agent.

Authors:  Elizabeth S Rowe; Vernon D Rowe; Sangita Biswas; Gerold Mosher; Lovella Insisienmay; Marlies K Ozias; Michael R Gralinski; John Hunter; James S Barnett
Journal:  J Neuroimaging       Date:  2016-05-12       Impact factor: 2.486

Review 5.  Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis.

Authors:  Ziliang Ye; Haili Lu; Qiang Su; Wenqin Guo; Weiran Dai; Hongqing Li; Huafeng Yang; Lang Li
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Protective Effect of Artemisia argyi and Its Flavonoid Constituents against Contrast-Induced Cytotoxicity by Iodixanol in LLC-PK1 Cells.

Authors:  Dahae Lee; Chang-Eop Kim; Sa-Yoon Park; Kem Ok Kim; Nguyen Tuan Hiep; Dongho Lee; Hyuk-Jai Jang; Jae Wook Lee; Ki Sung Kang
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

7.  Effect of Repeated Injection of Iodixanol on Renal Function in Healthy Wistar Rats Using Functional MRI.

Authors:  Yongfang Wang; Ke Ren; Lizhi Xie; Wenge Sun; Yi Liu; Songbai Li
Journal:  Biomed Res Int       Date:  2018-04-04       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.